Applications of topical immunomodulators enhance clinical signs of vernal keratoconjunctivitis (VKC) and atopic keratoconjunctivitis (AKC): a meta-analysis
ConclusionsThis study affirms the current scientific community's stance that immunomodulators effectively treat clinical signs, including blepharitis, conjunctival hyperemia, edema, papillae, and corneal damage in severe ocular allergic disease.
Source: International Ophthalmology - Category: Opthalmology Source Type: research
More News: Allergy & Immunology | Blepharitis | Opthalmology | Prograf | Restasis | Study | Tacrolimus